Sauna Therapy for Long Covid

Recruiting in Palo Alto (17 mi)

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Recruiting

Sponsor: Massachusetts General Hospital

No Placebo Group

Approved in 3 Jurisdictions

Trial Summary

What is the purpose of this trial?

Research suggests that Whole Body Hyperthermia in a sauna-like environment can reduce symptoms related to post-acute sequelae of SARS-CoV-2 (PASC), or Long Covid. The investigators aim to study the feasibility and treatment effect of this procedure for patients experiencing Long Covid symptoms.

Eligibility Criteria

This trial is for adults aged 18-65 who've had COVID-19 and suffer from Long Covid fatigue. They must be able to lie on their back for sauna sessions, use birth control if applicable, and not have any serious unstable medical conditions or certain mental health disorders.

Inclusion Criteria

I can lie on my back for 2 hours.

I had COVID-19 symptoms and tested positive for it over 12 weeks ago.

I am between 18 and 65 years old.

Exclusion Criteria

I am not on medications that affect body temperature regulation.

You have a history of certain mental health conditions or substance abuse within the last year.

I have a history or current diagnosis of blood clots.

Participant Groups

The study tests the effects of Whole Body Hyperthermia in a sauna-like setting on Long Covid symptoms. Participants will undergo this treatment to see if it can reduce fatigue associated with Post-COVID Syndrome.

Group I: verum whole body hyperthermia Experimental Treatment 1 Intervention

WBH will be completed with a Clearlight Sauna Dome and ancillary equipment to monitor core body temperature. For the verum WBH, participants will be brought to a core body temperature of 101.3°F.

Group II: sham whole body hyperthermia Placebo Group 1 Intervention

The sham condition will be identical to the active WBH condition. Time and other procedures will be consistent. Mild heat will be used to mimic an active WBH session.

Whole Body Hyperthermia is already approved in European Union, United States, Switzerland for the following indications:

🇪🇺 Approved in European Union as Whole Body Hyperthermia for:

• Depression
• Other conditions

🇺🇸 Approved in United States as Whole Body Hyperthermia for:

• Major Depressive Disorder

🇨🇭 Approved in Switzerland as Whole Body Hyperthermia for:

• Depression

Find a Clinic Near You

Research Locations Nearby Select from list below to view details:

Depression Clinical and Research Program Boston, MA

Who Is Running the Clinical Trial?

Massachusetts General Hospital Lead Sponsor

University of California, San Francisco Collaborator

References